StockData

Nika Pharmaceuticals, Inc (NIKA) stock

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

Nika Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Nika Pharmaceuticals's total debt was $340.62K at Jun 30, 2026. For fiscal 2025 it was $318.62K, up 33.2% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$318.62K+33.2%
FY2024Dec 31, 2024$239.16K+135.1%
FY2023Dec 31, 2023$101.75K+459.7%
FY2022Dec 31, 2022$18.18K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$340.62K+19.9%
Q1 FY2026Mar 31, 2026$331.62K+23.2%
Q4 FY2025Dec 31, 2025$318.62K+33.2%
Q3 FY2025Sep 30, 2025$284.16K+35.2%
Q2 FY2025Jun 30, 2025$284.16K+10.7%
Q1 FY2025Mar 31, 2025$269.16K+164.5%
Q4 FY2024Dec 31, 2024$239.16K+178.9%
Q3 FY2024Sep 30, 2024$210.16K+177.5%
Q1 FY2024Mar 31, 2024$256.62K+520.7%
Q4 FY2023Dec 31, 2023$101.75K+459.7%
Q3 FY2023Sep 30, 2023$85.75K–
Q2 FY2023Jun 30, 2023$75.75K–
Q1 FY2023Mar 31, 2023$41.35K–
Q4 FY2022Dec 31, 2022$18.18K–

More Nika Pharmaceuticals figures

See a number that looks wrong?